HCP
ACH

Hexagon Capital Partners’s Accendra Health ACH Stock Holding History

Hexagon Capital Partners’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-289
Closed -$2.61K – 1200
2025
Q1 		$2.61K Buy
289
+26
+10% +$275 ﹤0.01% 1332
2024
Q4 		$3.44K Sell
263
-243
-48% -$3.24K ﹤0.01% 1285
2024
Q3 		$7.94K Sell
506
-178
-26% -$2.7K ﹤0.01% 979
2024
Q2 		$9.23K Sell
684
-884
-56% -$18.1K ﹤0.01% 895
2024
Q1 		$43.4K Buy
1,568
+1,451
+1,240% +$32.2K 0.01% 462
2023
Q4 		$2.25K Buy
117
+6
+5% +$109 ﹤0.01% 1107
2023
Q3 		$1.79K Sell
111
-11
-9% -$195 ﹤0.01% 1091
2023
Q2 		$2.32K Sell
122
-39
-24% -$696 ﹤0.01% 1050
2023
Q1 		$2.34K Sell
161
-242
-60% -$4.33K ﹤0.01% 1038
2022
Q4 		$7.87K Buy
403
+71
+21% +$1.39K ﹤0.01% 787
2022
Q3 		$8K Buy
332
+153
+85% +$4.71K ﹤0.01% 827
2022
Q2 		$6K Buy
179
+167
+1,392% +$6.05K ﹤0.01% 770
2022
Q1 		$1K Buy
+12
New +$515 ﹤0.01% 872

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hexagon Capital Partners's ACH Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 289 shares — an estimated $2.61K sold.

Hexagon Capital Partners first reported a position in ACH in Q1 2022 and held it in 13 quarters. The position peaked at $43.4K in Q1 2024. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 289 Accendra Health shares in Q2 2025, an estimated $2.61K.
  • Hexagon Capital Partners first reported a position in Accendra Health in Q1 2022 and held it in 13 quarters.
  • Hexagon Capital Partners's Accendra Health position peaked at $43.4K in Q1 2024.
  • 234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.